AzTrials
AzTrials

Feeding Tube ComplicationFIXITNCT05694299

Nasal Bridle Versus Nasal Patch for Fixation of Nasoenteral Feeding Tubes

A study testing Nasal bridle and Nasal patch in people with Feeding Tube Complication and Feeding Disorders, run by Gelre Hospitals at 2 sites in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Aim of this study is to compare fixation of nasoenteral feeding tubes using either a nasal patch or a nasal bridle in clinical patients with regard to the occurrence of tube dislocation, complications, and discomfort. 78 (2 * 39) eligible patients will be included in this randomized controlled trial. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Feeding Tube Complication, Feeding Disorders
What is being tested?
Nasal bridle and Nasal patch
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
2 sitesNetherlands
Study dates
1 Nov 2021to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult patient (18 years or older)
  • received a nasoenteral feeding tube while being hospitalized
  • providing written informed consent

Who cannot join

  • contraindication for a nasal bridle (e.g., cleft lip or damaged nasal mucosa)
  • clinical need to place a nasal bridle
  • anticipated feeding nasoenteral feeding tube placement for < 3 days
  • failure of nasoenteral feeding tube placement

Trial locations and contacts

2 sites in 1 country.

Tjard Schermer, PhD contact

+31(0)655102377

t.schermer@gelre.nl

Netherlands2 sites, 1 recruiting
  • Gelre Hospitals

    Apeldoorn

    Active, not recruiting
  • Medisch Spectrum Twente

    Enschede

    Mariël Klos, +31(0)640973307, mariel.klos@MST.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Nasal Bridle Versus Nasal Patch for Fixation of Nasoenteral Feeding Tubes: a Randomized Controlled Clinical Trial

Aim of this study is to compare fixation of nasoenteral feeding tubes using either a nasal patch or a nasal bridle in clinical patients with regard to the occurrence of tube dislocation, complications, and discomfort. 78 (2 * 39) eligible patients will be included in this randomized controlled trial. The study is executed in two general teaching hospitals in the Netherlands (Gelre Hospitals Apeldoorn and Medical Spectrum Twente).

Being tested
Nasal bridle, Nasal patch
Medical subject headings
Feeding and Eating Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nasal bridleDevice

    Bridle Pro® Nasal Tube Retaining System (Applied Medical Technology Inc., Brecksville, OH, USA)

  • Nasal patchOther

    Regular adhesive tape for medical use.

Study groups in NCT05694299
Study groupRoleWhat they receive
Nasal bridleExperimentalNasal bridle fixation after nasoenteral feeding tube placement.
Receives: Device: Nasal bridle
Nasal patchActive comparatorNasal patch fixation after nasoenteral feeding tube placement.
Receives: Other: Nasal patch

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Premature dislocation of feeding tube

    Occurrence of a first premature dislocation of the feeding tube

    Measured: Within 14 days after initial placement of the feeding tube

Secondary outcomes (3)
  1. Complications related to fixation of the feeding tube

    Occurence of nasal pressure ulcer (grade and location); sinusitis (running nose; nasal congestion); facial pain or pressure; dysosmia; frequent sneezing; epistaxis

    Measured: During the 14-day period after initial placement of the feeding tube

  2. Pain experienced from the nasal fixation

    Pain scored on a visual analogue scale (VAS) with a minimum score of 0 and a maximum score of 100

    Measured: During the 14-day period after initial placement of the feeding tube

  3. Discomfort experienced from the nasal fixation

    Discomfort scored on a visual analogue scale (VAS) with a minimum score of 0 and a maximum score of 100

    Measured: During the 14-day period after initial placement of the feeding tube

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2023
  2. Study start1 Nov 2021
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05694299
Sponsor's protocol ID
2021_67
Other IDs
210808 (FIXIT)
Acronym
FIXIT
Status last verified
Jan 2023
First submitted
12 Jan 2023
Last updated
25 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The IPD sharing plan has not been finished yet, scheduled for Q4 2023.

Questions about this trial

What is this clinical trial studying?

A study testing Nasal bridle and Nasal patch in people with Feeding Tube Complication and Feeding Disorders, run by Gelre Hospitals at 2 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tjard Schermer, PhD (+31(0)655102377, t.schermer@gelre.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Premature dislocation of feeding tube (time frame: Within 14 days after initial placement of the feeding tube). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in